Detalhe da pesquisa
1.
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults.
Blood
; 141(25): 3019-3030, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018730
2.
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Blood
; 142(24): 2105-2118, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562003
3.
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(9): e29123, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061452
4.
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv
; 7(12): 2758-2771, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857419